Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 22
208
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

Study of potent CDK7 inhibitor secondary metabolites from Tecomella undulata

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 5793-5797 | Received 17 Sep 2021, Accepted 28 Nov 2021, Published online: 04 Jan 2022

References

  • Ali S, Heathcote DA, Kroll SHB, Jogalekar AS, Scheiper B, Patel H, Brackow J, Siwicka A, Fuchter MJ, Periyasamy M, et al. 2009. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res. 69(15):6208–6215.
  • Chen YZ, Ung CY. 2001. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J Mol Graph Model. 20(3):199–218.
  • Chopra RN, Nayar SL, Chopra IC. 1956. Glossary of Indian medicinal plants. New Delhi: CSIR; p. 240.
  • Greber BJ, Perez-Bertoldi JM, Lim K, Iavarone AT, Toso DB, Nogales E. 2020. The cryoelectron microscopy structure of the human CDK-activating kinase. Proc Natl Acad Sci USA. 117(37):22849–22857.
  • Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL. 2004. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 47(7):1750–1759.
  • Jagbir C, Vinod K, Sunil K. 2011. A phytopharmacological overview on Tecomella undulata G. Don. J Appl Pharm Sci. 01(01):11–12.
  • Khamthong N, Rukachaisirikul V, Tadpetch K, Kaewpet M, Phongpaichit S, Preedanon S, Sakayaroj J. 2012. Tetrahydroanthraquinone and xanthone derivatives from the marine-derived fungus Trichoderma aureoviride PSU-F95. Arch Pharm Res. 35(3):461–468.
  • Khandelwal P, Singh P. 2008. Tabebuin and tecomaquinone-III-dimeric quinones from Tabebuia rosea. J Indian Chem Soc. 85:310–312.
  • Khandelwal P, Singh P, Taniguchi T, Monde K, Johmoto K, Uekusa H, Masubuti H, Fujimoto Y. 2014. Revision of the relative and absolute stereochemistries of 3-hydroxy-dehydroiso-α-lapachone and its 8-hydroxy derivative. Phytochem Lett. 10:224–229.
  • Kirtikar KR, Basu BP. 1993. Indian medicinal plants. Int Book Distrib. 1111:1841–1842.
  • Krishna V, Khandelwal P, Koolwal N, Sharma MC, Singh P. 2012. Quinonoid molecular diversity in Bignoniaceae and its taxonomic significance. J Indian Chem Soc. 89:1019–1024.
  • Kuo SC, Chen PR, Lee SW, Chen ZT. 1995. Constituents of roots of Rubia lanceolata Hayata. J Chin Chem Soc. 42(5):869–871.
  • Pandey VB, Dasgupta B. 1970. A new ester glucoside from the bark of Tecomella undulata. Experientia. 26(11):1187–1188.
  • Paranjpe P. 2001. Indian medicinal plants :forgotten healers: A guide to ayurvedic herbal medicine. Chaukhamba Sanskrit Pratisthan, Delhi, India; p. 223–224.
  • Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W. 2013. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 27(3):221–234.
  • Singh P, Khandelwal P, Hara N, Asai T, Fujimoto Y. 2008. Radermachol and naphthoquinone derivatives from Tecomella undulata: complete 1H and 13C NMR assignments of radermachol with the aid of computational 13C shift prediction. Indian J Chem. 47B:1865–1870.
  • Singh G, Singh A, Verma RK, Mall R, Azeem U. 2018. Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives. Comput Biol Chem. 72:45–52.
  • Vyas P, Wadhwani BD, Khandelwal P, Araya H, Fujimoto Y. 2020. Tectonaquinones A, B and C: three new naphthoquinone derivatives from the heartwood of Tectona grandis. Nat Prod Res (Formerly Natural Product Letters).:doi:10.1080/14786419.2020.1810035.
  • Vyas P, Yadav DK, Khandelwal P. 2019. Tectona grandis (teak) – a review on its phytochemical and therapeutic potential. Nat Prod Res (Formerly Natural Product Letters). 33(16):2338–2354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.